Carotuximab (Synonyms: TRC105; DE-122) |
| Catalog No.GC68833 |
Carotuximab (TRC105) is an IgG1 monoclonal antibody that can block endoglin (CD105) and its downstream Smad signaling pathway. Carotuximab has immunomodulatory and anti-tumor effects.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1268714-50-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Carotuximab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Carotuximab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *